| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |